KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Shares Issued (2018 - 2025)

Aquestive Therapeutics (AQST) has 8 years of Shares Issued data on record, last reported at -$236000.0 in Q4 2025.

  • For Q4 2025, Shares Issued fell 133.62% year-over-year to -$236000.0; the TTM value through Dec 2025 reached $110000.0, down 84.97%, while the annual FY2025 figure was $110000.0, 84.97% down from the prior year.
  • Shares Issued reached -$236000.0 in Q4 2025 per AQST's latest filing, down from $296000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $24.5 million in Q3 2021 and bottomed at -$24.4 million in Q4 2021.
  • Average Shares Issued over 5 years is $76142.9, with a median of $44500.0 recorded in 2023.
  • Peak YoY movement for Shares Issued: tumbled 15930.65% in 2021, then soared 1700.0% in 2024.
  • A 5-year view of Shares Issued shows it stood at -$24.4 million in 2021, then skyrocketed by 99.94% to -$15000.0 in 2022, then soared by 360.0% to $39000.0 in 2023, then skyrocketed by 1700.0% to $702000.0 in 2024, then crashed by 133.62% to -$236000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were -$236000.0 in Q4 2025, $296000.0 in Q3 2025, and $50000.0 in Q2 2025.